![Kendra Adams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kendra Adams
Finansdirektör/CFO på
C4 THERAPEUTICS, INC.
Förmögenhet: 197 406 $ per 2026-05-31
Profil
Kendra R.
Adams is currently Treasurer, Chief Financial & Accounting Officer at C4 Therapeutics, Inc. since 2026.
Former positions include Director-Investor Relations at ARIAD Pharmaceuticals, Inc. and VP-External Communications & Investor Relations at Agios Pharmaceuticals, Inc. Education includes undergraduate studies at Hamilton College (New York).
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
C4 THERAPEUTICS, INC. 0,04 % | 2026-04-22 | 45 173 ( 0,04 % ) | 197 406 $ | 2026-05-31 |
Aktiva positioner av Kendra Adams
| Företag | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Finansdirektör/CFO | 2023-09-18 |
Tidigare kända positioner av Kendra Adams
| Företag | Position | Slut |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
| ARIAD PHARMACEUTICALS, INC. | Investor Relations Kontakt | - |
Utbildning av Kendra Adams
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
9
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
